Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery

Abstract

This study aimed to examine the preparation of cationic lipid microbubble (CLM), and evaluate its physical and chemical properties and toxicity, measure the gene transfection efficiency by ultrasound triggered microbobble destruction (UTMD) in combination with CLM. The CLM was prepared by the method of the thin film hydration, and its morphology was observed under the electron microscopy at 1st, 3rd, 7th, 10th, and 14th day after preparation, respectively. The size, Zeta potential and stability of CLM were tested. The acute toxicity of CLM was assessed. The green fluorescent protein gene (EGFP) transfection efficiency was evaluated. The experiment grouping was as follows: naked plasmid group (P group), ultrasonic irradiation plus naked plasmid group (P-US group), naked plasmid plus CLM group (P-CLM group), naked plasmid plus ultrasound and CLM group (UTMD group). The expression of EGFP was detected by fluorescent microscopy and flow cytometry. The results showed that CLMs were spherical in shape, with the similar size and good distribution degree under the light and electron microscopies. The size of CLMs was varied from 250.4±88.3 to 399.0±99.8 nm and the Zeta potential of CLMs from 18.80±4.97 to 20.1±3.1 mV. The EGFP expression was the strongest in the UTMD group, followed by the P-CLM group, P-US group and P group. Flow cytometry results were consistent with those of fluorescent microscopy. The transfection efficiency was substantially increased in the P-US group, P-CLM group and UTMD group as compared with that in the P group, almost 7 times, 10 times and 30 times higher than that in the P group respectively. It is suggested that CLMs prepared by the method of thin film hydration are uniform in diameter, and proved non-toxic. UTMD combined with CLM can significantly increase the transfection efficiency of EGFP to targeted cells.

Keywords

ultrasound triggered microbubble destruction / RNA interference / gene

References

[1] RenJ., XuC., ZhouZ., et al.. A novel ultrasound microbubble carrying gene and Tat peptide: preparation and characterization. Acad Radiol, 2009, 16(12): 1457-1465

[2] KlibanovA.L.. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol, 2006, 41(3): 354-362

[3] FerraraK.W., BordenM.A., ZhangH.. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res, 2009, 42(7): 881-892

[4] ChomasJ.E., DaytonP., AllenJ., et al.. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control, 2001, 48(1): 232-248

[5] StrideE.P., CoussiosC.C.. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proc Inst Mech Eng H, 2010, 224(2): 171-191

[6] MayerC.R., BekeredjianR.. Ultrasonic gene and drug delivery to the cardiovascular system. Adv Drug Deliv Rev, 2008, 60(10): 1177-1192

[7] BekeredjianR., GrayburnP.A., ShohetR.V.. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol, 2005, 45(3): 329-335

[8] DijkmansP.A., JuffermansL.J., MustersR.J., et al.. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr, 2004, 5(4): 245-256

[9] BouakazA., VersluisM., de JongN.. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol, 2005, 31(3): 391-399

[10] de JongN., EmmerM., van WamelA., et al.. Ultrasonic characterization of ultrasound contrast agents. Med Biol Eng Comput, 2009, 47(8): 861-873

[11] GaoX., HuangL.. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun, 1991, 179(1): 280-285

[12] FelgnerJ.H., KumarR., SridharC.N., et al.. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem, 1994, 269(4): 2550-2561

[13] Le GallT., LoizeauD., PicquetE., et al.. A novel cationic lipophosphoramide with diunsaturated lipid chains: synthesis, physicochemical properties, and transfection activities. J Med Chem, 2010, 53(4): 1496-1508

[14] AkowuahE.F., GrayC., LawrieA., et al.. Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther, 2005, 12(4): 1154-1157

[15] BekeredjianR., ChenS., FrenkelP.A., et al.. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation, 2003, 108(8): 1022-1026

[16] ChenS., ShohetR.V., BekeredjianR., et al.. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol, 2003, 42(2): 301-308

[17] GeisN.A., MayerC.R., KrollR.D., et al.. Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability. Ultrasound Med Biol, 2009, 35(7): 1119-1126

[18] LiangH.D., LuQ.L., XueS.A., et al.. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol, 2004, 30(11): 1523-1529

[19] OhlC.D., AroraM., IkinkR., et al.. Sonoporation from jetting cavitation bubbles. Biophys J, 2006, 91(11): 4285-4295

[20] SongY.K., LiuF., ChuS., et al.. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther, 1997, 8(3): 1585-1594

[21] VitielloL., ChonnA., WassermanJ.D., et al.. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Ther, 1996, 3(5): 396-404

[22] SmithD.A., PorterT.M., MartinezJ., et al.. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol, 2007, 33(5): 797-809

[23] OberdörsterG., SharpZ., AtudoreiV., et al.. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol, 2004, 16(6–7): 437-445

[24] UngerE.C., McCreeryT.P., SweitzerR.H., et al.. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol, 1998, 33(12): 886-892

[25] ChenL., ter HaarG., HillC.R., et al.. Treatment of implanted liver tumors with focused ultrasound. Ultrasound Med Biol, 1998, 24(9): 1475-1488

[26] LiangH.D., LuQ.L., XueS.A., et al.. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol, 2004, 30(11): 1523-1529

[27] FisherN.G., ChristiansenJ.P., KlibanovA., et al.. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol, 2002, 40(4): 811-819

[28] JanickiS., JankowskiJ., SzulcJ., et al.. The effect of cryoprotectants on the physical properties of large liposomes containing sodium diclofenac. Acta Pol Pharm, 2002, 59(3): 187-191

[29] HasikM.J., KimD.H., HowleL.E., et al.. Evaluation of synthetic phospholipid ultrasound contrast agents. Ultrasonics, 2002, 40(9): 973-982

[30] El-SherifD.M., LathiaJ.D., LeN.T., et al.. Ultrasound degradation of novel polymer contrast agents. J Biomed Mater Res A, 2004, 68(1): 71-78

[31] CaraccioloG., CallipoL., De SanctisS.C., et al.. Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum. Biochim Biophys Acta, 2010, 1798(3): 536-543

[32] SchratzbergerP., KraininJ.G., SchratzbergerG., et al.. Transcutaneous ultrasound augments naked DNA transfection of skeletal muscle. Mol Ther, 2002, 6(5): 576-583

[33] Leong-PoiH., KuliszewskiM.A., LekasM., et al.. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res, 2007, 101(3): 295-303

[34] StrideE.P., CoussiosC.C.. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proc Inst Mech Eng H, 2010, 224(2): 171-191

[35] StrideE.. Physical principles of microbubbles for ultrasound imaging and therapy. Cerebrovasc Dis, 2009, 27(Suppl2): 1-13

[36] FerraraK.W., BordenM.A., ZhangH.. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res, 2009, 42(7): 881-892

[37] TartisM.S., KruseD.E., ZhengH., et al.. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Control Release, 2008, 131(3): 160-166

[38] ChristiansenJ.P., FrenchB.A., KlibanovA.L., et al.. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol, 2003, 29(12): 1759-1767